Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
eHealthFRA:M5V +0.43%49 5-Year Yield-on-Cost % is 0.00 as of Jul. 29, 2026. GuruFocus rates FRA:M5V with a GF Score™ of 49/100 and a GF Value™ of €4.02 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 420 Insurance companies, eHealth ranks worse than 238095% on this metric.
eHealth's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for eHealth's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:M5V's 5-Year Yield-on-Cost % is not ranked *
in the Insurance industry.
Industry Median: 3.84 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
eHealth 5-Year Yield-on-Cost % Related Terms
FRA:M5V vs XHG, QDMI, HUIZ: 5-Year Yield-on-Cost % Comparison
For the Insurance Brokers subindustry, eHealth's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
eHealth 5-Year Yield-on-Cost % vs Insurance Industry
For the Insurance industry and Financial Services sector, eHealth's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where eHealth's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of eHealth is calculated as
eHealth (FRA:M5V) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 29, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on eHealth and its competitors. According to the industry distribution chart, eHealth ranks #999999 out of 420 companies in the Insurance industry.
Is eHealth's 5-Year Yield-on-Cost % too high?
eHealth's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, eHealth ranks #999999 out of 420 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, eHealth has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does eHealth's 5-Year Yield-on-Cost % compare to XHG and QDMI?
According to the Insurance industry distribution chart, eHealth ranks #999999 out of 420 companies for 5-Year Yield-on-Cost %. This places eHealth in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Insurance company?
The median 5-Year Yield-on-Cost % among Insurance companies is 3.84, based on 420 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on eHealth and its competitors. For the Insurance industry, the median 5-Year Yield-on-Cost % is 3.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. eHealth's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is eHealth stock overvalued right now?
Based on GuruFocus' analysis, eHealth (FRA:M5V) is currently considered Possible Value Trap. The stock's GF Value™ is €4.02, compared to a current price of €1.17 — trading 70.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. eHealth's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For eHealth (FRA:M5V), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is eHealth (FRA:M5V) Overvalued in 2026?
Based on GuruFocus' analysis, eHealth stock appears to be undervalued.
The current stock price of €1.17 is trading 70.9% below its estimated GF Value™ of €4.02.
GuruFocus considers eHealth to be Possible Value Trap.
Key valuation signals for FRA:M5V:
5-Year Yield-on-Cost %: 0.00
GF Value™: €4.02 vs. price of €1.17 (70.9% below fair value)
No single metric tells the full story. See the FRA:M5V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.
49GF Score
Get the complete analysis for FRA:M5V
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M5V has been successfully added to your 
